Your browser doesn't support javascript.
Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations.
Gorodensky, Ariel; Bowra, Andrea; Saeed, Gul; Kohler, Jillian.
  • Gorodensky A; University of Toronto Leslie Dan Faculty of Pharmacy, Toronto, Ontario, Canada.
  • Bowra A; University of Toronto Dalla Lana School of Public Health, Toronto, Ontario, Canada.
  • Saeed G; WHO Collaborating Centre for Governance, Accountability, and Transparency in the Pharmaceutical Sector, Toronto, Ontario, Canada.
  • Kohler J; Yale School of Public Health, Yale University, New Haven, CT, USA.
BMJ Open ; 12(12): e064137, 2022 12 22.
Article in English | MEDLINE | ID: covidwho-2193777
ABSTRACT

OBJECTIVES:

Corruption undermines the quality of healthcare and leads to inequitable access to essential health products. WHO, Global Fund, United Nations Development Programme (UNDP) and World Bank are engaged in anti-corruption in health sectors globally. Throughout the COVID-19 pandemic, weakened health systems and overlooked regulatory processes have increased corruption risks. The objective of this study is thus to explore the strengths and weaknesses of these organisations' anti-corruption mechanisms and their trajectories since the pandemic began. DESIGN, SETTING AND

PARTICIPANTS:

25 semistructured key informant interviews with a total of 27 participants were conducted via Zoom between April and July 2021 with informants from WHO, World Bank, Global Fund and UNDP, other non-governmental organisations involved in anti-corruption and academic institutions. Key informant selection was guided by purposive and snowball sampling. Detailed interview notes were qualitatively coded by three researchers. Data analysis followed an inductive-deductive hybrid thematic analysis framework.

RESULTS:

The findings demonstrate that WHO, World Bank, Global Fund and UNDP have shifted from criminalisation/punitive approaches to anti-corruption to preventative ones and that anti-corruption initiatives are strong when they are well funded, explicitly address corruption and are complemented by strong monitoring and evaluation mechanisms. Weaknesses in the organisations' approaches to anti-corruption include one-size-fits-all approaches, lack of political will to address corruption and zero-tolerance policies for corruption. The COVID-19 pandemic has highlighted the necessity of improving anti-corruption by promoting strong accountability and transparency in health systems.

CONCLUSIONS:

Results from this study highlight the strengths, weaknesses and recent trajectories of anti-corruption in the Global Fund, World Bank, UNDP and WHO. This study underscores the importance of implementing strong and robust anti-corruption mechanisms specifically geared towards corruption prevention that remain resilient even in times of emergency.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Global Health / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research Limits: Humans Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: Bmjopen-2022-064137

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Global Health / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research Limits: Humans Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: Bmjopen-2022-064137